Decoding 23andMe’s downfall

DNA testing firm 23andMe has filed for bankruptcy protection in the US. Chief executive Anne Wojcicki has stepped down, after several failed bids to buy the company herself. The Chapter 11 process will allow the loss-making company to restructure and sell itself, with protection from its creditors. Perhaps the biggest question this raises is: what happens to the millions of people’s genetic data and samples that the company currently holds?